me 2303 has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariyoshi, Y; Ogawa, M | 1 |
| Blazsek, I; Comisso, M; Kitasato, H; Mathé, G; Umezawa, H; Umezawa, K | 1 |
1 review(s) available for me 2303 and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[New anthracyclines].
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Carubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Menogaril; Stomach Neoplasms | 1993 |
1 trial(s) available for me 2303 and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[New anthracyclines].
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Carubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Menogaril; Stomach Neoplasms | 1993 |
1 other study(ies) available for me 2303 and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
The differentiation-promoting potential of a cytostatic fluoro-pyranosyl adriamycin analog (FAD 104).
Topics: Antineoplastic Agents; Bone Marrow; Colony-Forming Units Assay; Doxorubicin; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute | 1989 |